Vermont Governor: To Combat Opioid Crisis, the Way Pain Pills Are Prescribed Must Change

Vermont Gov. Peter Shumlin delivers his final State of the State Address on Thursday, Jan. 7, 2016, at the Statehouse in Montpelier, Vt.

Vermont Gov. Peter Shumlin delivers his final State of the State Address on Thursday, Jan. 7, 2016, at the Statehouse in Montpelier, Vt. Andy Duback / AP Photo

 

Connecting state and local government leaders

“It isn’t the drug dealers from South America that are our biggest challenge, it’s our federally-approved drugs that we’re passing out like candy,” according to Gov. Peter Shumlin.

WASHINGTON — Blasting big pharmaceutical companies, and raising questions about the influence their lobbying dollars have over federal policy, Vermont Gov. Peter Shumlin on Friday argued that stemming the sharp rise in painkiller and heroin addiction that has plagued his and other states will require changes in the way pain medication is prescribed.

“I can explain our challenge not in words, but with three letters: F, D, A,” the governor said, referring to the U.S. Food and Drug Administration.

“It isn’t the drug dealers from South America that are our biggest challenge, it’s our federally-approved drugs that we’re passing out like candy,” he added. “This town is a tough place to talk about it. Why? A few years ago big pharma gave enough money to lobby for their causes so that it works out, if you divide it . . . to $435,000 per congressperson.”

Shumlin delivered his remarks during a talk at The Pew Charitable Trusts’ offices in the nation’s capital, in which he discussed his state’s efforts to push back against the swell of opioid addiction.

Of the 47,055 deadly drug overdoses in the U.S. in 2014, 18,893 were related to prescription painkillers, according to figures published by the Centers for Disease Control and Prevention. That’s compared to 4,400 in 2000.

Between those same two years, deaths from heroin overdoses also climbed steadily to 10,574, from 1,842. Misuse of prescription pain medicine is often seen as a pathway toward heroin.

Food and Drug Administration officials earlier this month announced a plan to reassess the agency’s approach to opioid medications.

Some of the facets of that plan are the expanded use of advisory committees to review new opioid drugs before they are approved, changes to labeling for certain medicines, and incorporating the broader public health effects of opioid abuse into drug approval decisions.

In his State of the State address in January, Shumlin proposed restricting the number of pain pills that can be prescribed for minor procedures to 10, while also considering new limits on the number that can be prescribed in more serious cases as well.

A Democrat now in a third, two-year term that will end in 2017, Shumlin has said he will not seek re-election. During his time in office, he has been active on the issue of combating opioid addiction, and devoted most of his 2014 State of the State address to the topic.

In early February, he slammed two pharmaceutical companies, AstraZeneca and Daiichi Sankyo, for running a television advertisement during the Super Bowl, which urged people experiencing constipation from long-term opioid use to ask their doctors about treatment options to alleviate the condition. Shumlin called the advertisement “poorly timed" and "shameful.”

On Friday, the governor pointed to a number of strides Vermont has taken to help people who are struggling with opioid and heroin addiction. The state, he said, has built out treatment centers, made sure first responders have Naloxone, a drug that can counteract the potentially lethal effects of opioid overdoses, and has also worked to change attitudes, so that those with addictions are seen as having a disease rather than as criminals.

But the root of the problem, Shumlin contends, is the amount of prescription pain medicine that has been getting distributed by doctors, dentists and other healthcare providers in recent years.

“In 2010, we prescribed enough OxyContin in America to keep every single adult high for a month,” the governor said.

Citing the Centers for Disease Control and Prevention, an American Society of Addiction Medicine fact sheet issued this year said that in 2012, 259 million prescriptions were written in the U.S. for opioids. The nation’s population was about 321 million people in 2015.

“Until and unless we are willing as a nation to have the conversation about the way we are prescribing painkillers in America, you will see future governors stand before you, as I am today, talking about a tragedy that is killing 131 Americans a day,” Shumlin warned. He added: “We have got to change the way we are prescribing painkillers.”

PREVIOUSLY on Route Fifty: "New England Struggles to Counter Heroin Addiction"

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.